- Home
- UHG vs CLNN Comparison
UHG vs CLNN Comparison
Compare UHG & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UHG | CLNN |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | 175 | 76 |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 69.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | UHG | CLNN |
|---|---|---|
| Price | $1.16 | $5.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | ★ 569.0K | 67.3K |
| Earning Date | 03-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.20 |
| Revenue Next Year | N/A | $20,465.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $2.28 |
| 52 Week High | $4.78 | $13.50 |
Technical Indicators
Market Signals| Indicator | UHG | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 33.17 | 47.84 |
| Support Level | $1.15 | $3.54 |
| Resistance Level | $1.81 | $5.71 |
| Average True Range (ATR) | 0.02 | 0.55 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 12.50 | 23.71 |
Price Performance
Historical ComparisonAbout UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.